NTRA News and Press, Natera Inc. From 10/11/19

“We have been living and illusion that revenue and growth equals success. Even the press goes for it” -Bill Gurley 1) Invitae: The Amazon of Genetics? Invitae’s social mission is to provide affordable genetic testing for all. This has somehow earned the...

SAN CARLOS, Calif. , Oct. 3, 2019 /PRNewswire/ -- Natera, Inc.  (NASDAQ: NTRA ), a global leader in cell-free DNA testing, today announced it will review recent progress in its oncology business, including the positive draft local coverage decision for Signatera ™ in colo...

CAMBRIDGE, Mass. and SAN CARLOS, Calif. , Sept. 25, 2019 /PRNewswire/ -- Foundation Medicine, Inc. and Natera, Inc. (NASDAQ: NTRA) today announced a partnership to develop and commercialize personalized circulating tumor DNA (ctDNA) monitoring assays, for use by biopharmaceutical a...

LOS ANGELES , Sept. 13, 2019 /PRNewswire/ --  CBR (Cord Blood Registry), the world's largest newborn stem cell collection and storage company, today announced the asset acquisition of Natera, Inc. 's  (NASDAQ: NTRA) Evercord™ newborn stem cell business. The mutually ...

SAN CARLOS, Calif. , Sept. 13, 2019 /PRNewswire/ --  Natera, Inc.  (NASDAQ: NTRA) and   CBR (Cord Blood Registry )  today announced the acquisition by CBR, a California Cryobank Life Sciences company, and the world's largest newborn stem cell collection and storage...

SAN CARLOS, Calif. , Sept. 9, 2019 /PRNewswire/ --  Natera, Inc.  (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced the publication of the largest non-invasive prenatal test (NIPT) outcomes study to date, analyzing its Panorama ®  assay over a 4...

SAN CARLOS, Calif. , Sept. 4, 2019 /PRNewswire/ --  Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced it will webcast a live presentation at the Morgan Stanley 17th Annual Global Healthcare Conference at the Grand Hyatt New York on Wednesday, Se...

SAN CARLOS, Calif. , Aug. 29, 2019 /PRNewswire/ --  Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, has appointed Rowan Chapman , Ph.D., to its board of directors, effective August 15, 2019 . "We are extremely pleased to welcome Dr. Rowan Chapman ...

SAN CARLOS, Calif. , Aug. 28, 2019 /PRNewswire/ -- Natera, Inc.  (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced it will webcast a live presentation at the Baird 2019 Global Healthcare Conference at the InterContinental New York Barclay hotel in New York...

SAN CARLOS, Calif. , Aug. 22, 2019 /PRNewswire/ -- Natera, Inc.   (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that the Palmetto MolDX program has proposed a local coverage determination (LCD) for use of Natera's Signatera molecular resi...